NCT01186003View on ClinicalTrials.gov

Effectiveness of Adding Subcutaneous Long-Acting Detemir to Insulin Drip Therapy Compared With Standard Insulin Drip Therapy

NACompletedINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

August 31, 2010

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions

Diabetes

Interventions

DRUG

Detemir

Detemir 0.25 units per kg body weight given subcutaneously every 24 hours while patients are receiving intravenous (IV) standard insulin drip therapy

Trial Locations (1)

80045

University of Colorado Denver, Aurora

Sponsors

Collaborators (1)

Novo Nordisk A/S

All Listed Sponsors

collaborator

Novo Nordisk A/S

INDUSTRY

lead

University of Colorado, Denver

OTHER